Personal tools

MCL coexpression mm9:454: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002107!6.21e-22!22;UBERON:0007499!6.21e-22!22;UBERON:0006925!6.21e-22!22;UBERON:0009497!6.21e-22!22;UBERON:0000015!6.21e-22!22;UBERON:0002423!6.21e-22!22;UBERON:0006235!6.21e-22!22;UBERON:0008835!6.21e-22!22;UBERON:0003894!6.21e-22!22;UBERON:0004161!6.21e-22!22;UBERON:0008836!6.21e-22!22;UBERON:0009854!7.81e-21!23;UBERON:0009856!7.81e-21!23;UBERON:0002365!6.71e-19!25;UBERON:0002330!6.71e-19!25;UBERON:0005256!4.76e-09!45;UBERON:0003914!1.57e-08!47;UBERON:0005172!4.71e-08!49;UBERON:0005173!4.71e-08!49;UBERON:0002417!4.71e-08!49;UBERON:0000916!4.71e-08!49;UBERON:0003929!7.74e-07!55
|ontology_enrichment_uberon=UBERON:0002107!6.21e-22!22;UBERON:0007499!6.21e-22!22;UBERON:0006925!6.21e-22!22;UBERON:0009497!6.21e-22!22;UBERON:0000015!6.21e-22!22;UBERON:0002423!6.21e-22!22;UBERON:0006235!6.21e-22!22;UBERON:0008835!6.21e-22!22;UBERON:0003894!6.21e-22!22;UBERON:0004161!6.21e-22!22;UBERON:0008836!6.21e-22!22;UBERON:0009854!7.81e-21!23;UBERON:0009856!7.81e-21!23;UBERON:0002365!6.71e-19!25;UBERON:0002330!6.71e-19!25;UBERON:0005256!4.76e-09!45;UBERON:0003914!1.57e-08!47;UBERON:0005172!4.71e-08!49;UBERON:0005173!4.71e-08!49;UBERON:0002417!4.71e-08!49;UBERON:0000916!4.71e-08!49;UBERON:0003929!7.74e-07!55
|tfbs_overrepresentation_for_novel_motifs=0.19013,0.0414522,0.171413,0.630846,0.325044,0.232532,0.305009,0.416085,0.439801,0.0241551,0.26934,0.295134,0.0498401,0.315149,1.17512,0,0.482714,0.645746,0.379612,0.359873,0.146132,0.242916,0.3144,0.663197,0.176763,0.338177,0.156743,0.694761,0.126301,0.490013,0.237846,0.574932,0.0927567,0.314034,0.108791,0.0161089,0.0875334,0.292182,0.262298,0.0613737,0.656409,0.241862,2.36871,0.71889,0.118148,0.213039,0.41191,0.723497,1.0034,0.128181,0.467043,0.360991,1.50697,0.7073,0.723811,0.321095,0.417292,0.284741,0.145788,0.319396,0.556492,0.369066,0.215066,0.456979,0.330403,0.493315,0.854035,1.19441,0.552202,1.05011,0.158281,0.19416,0.453542,0.755651,0.0343898,0.0305002,0.0329844,1.03797,0.540754,0.148967,0.433876,0.498379,1.71362,0.0470048,0.646739,0.00962,0.0019315,0.107772,0.416206,1.35441,0.92132,0.6514,0.586758,0.102076,1.39003,0.231057,0.183077,0.589355,0.412133,0.681961,0.0875773,0.574674,0.690844,0.467576,1.17798,0.241519,0.52055,0.25809,2.08444,0.147333,0.185018,0.692526,0.457145,0.273484,0.928143,0.315992,0.00275197,0.224335,0.483885,0.604422,0.760792,0.438354,0.900811,0.40118,0.980682,0.544138,0.311744,0.580495,0.852575,0.339019,0.67485,0.617809,0.824167,0.332514,0.949083,0.0397143,1.08375,0.24296,0.901468,1.71991,1.32292,0.85857,0.349901,0.584599,0.46084,0.242215,0.414644,1.68046,0.575158,0.0996378,0.110319,0.212292,0.708784,0.23951,0.331737,0.786435,0.361851,0.115836,0.551917,0.196072,0.910663,0.645939,0.544546,0.183389,0.457889,0.869172,0.293289,0.797827,0.0128525
}}
}}

Revision as of 18:23, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:4922184..4922209,+p@chr10:4922184..4922209
+
Mm9::chr11:110006928..110006939,+p@chr11:110006928..110006939
+
Mm9::chr11:75475116..75475125,+p19@Myo1c
Mm9::chr13:60581723..60581732,-p@chr13:60581723..60581732
-
Mm9::chr16:33124135..33124150,-p@chr16:33124135..33124150
-
Mm9::chr2:153426878..153426919,+p@chr2:153426878..153426919
+
Mm9::chr2:158037521..158037530,-p@chr2:158037521..158037530
-
Mm9::chr3:107041575..107041625,-p1@Prok1
Mm9::chr4:11542152..11542159,-p1@ENSMUST00000148576
p1@uc008rzu.1
Mm9::chr4:138015834..138015847,-p@chr4:138015834..138015847
-
Mm9::chr4:41577595..41577612,+p@chr4:41577595..41577612
+
Mm9::chr4:41577627..41577640,+p@chr4:41577627..41577640
+
Mm9::chr5:22095470..22095488,-p@chr5:22095470..22095488
-
Mm9::chr7:14840233..14840239,-p1@Sult2a6
Mm9::chr7:85980668..85980685,-p@chr7:85980668..85980685
-
Mm9::chrX:136369277..136369283,-p@chrX:136369277..136369283
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0045160myosin I complex0.009203966471265
GO:0016461unconventional myosin complex0.0138051932993965
GO:0032420stereocilium0.0230042431219055
GO:0032421stereocilium bundle0.0230042431219055
GO:0008022protein C-terminus binding0.0239224461872794
GO:0005902microvillus0.0260664748441257
GO:0005903brush border0.0275967712637765
GO:0007623circadian rhythm0.0306555151069646
GO:0045765regulation of angiogenesis0.0306555151069646
GO:0000187activation of MAPK activity0.0331025101815151
GO:0043406positive regulation of MAP kinase activity0.0342681020504265
GO:0016459myosin complex0.0424111867249851
GO:0043405regulation of MAP kinase activity0.0424111867249851



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
liver6.21e-2222
epithelial sac6.21e-2222
digestive gland6.21e-2222
epithelium of foregut-midgut junction6.21e-2222
anatomical boundary6.21e-2222
hepatobiliary system6.21e-2222
foregut-midgut junction6.21e-2222
hepatic diverticulum6.21e-2222
liver primordium6.21e-2222
septum transversum6.21e-2222
liver bud6.21e-2222
digestive tract diverticulum7.81e-2123
sac7.81e-2123
exocrine gland6.71e-1925
exocrine system6.71e-1925
trunk mesenchyme4.76e-0945
epithelial tube1.57e-0847
abdomen element4.71e-0849
abdominal segment element4.71e-0849
abdominal segment of trunk4.71e-0849
abdomen4.71e-0849
gut epithelium7.74e-0755


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}